Companies / Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.

Nasdaq: RYTMCIK 1649904BOSTON, MArhythmtx.com

Financials · FY2025

Revenue$189.76M
Net income$-196.54M
Total debt$93.40M
Cash$65.61M
Diluted EPS$-3.11
Shares outstanding68.9M

Ownership

68.9M shares outstanding · as of Aug 1, 2026
0.77%Insiders
Ownership
Insiders0.77%533,428
10%+ / strategic14.07%9,689,585
Institutions92.94%63,990,778
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 13

View all →
Insider% of sharesShares
Meeker David PCEOPresident and CEO · Director
0.35%239,016
Smith Hunter CChief Financial Officer
0.17%116,611
Mazabraud YannEVP, Head of International
0.08%53,155
Cramer Pamela J.Chief Human Resources Officer
0.04%29,376
Lee Jennifer KaydenEVP, Head of North America
0.03%19,233
Shulman JosephChief Technical Officer
0.03%18,970
0.02%14,168
0.02%11,712
0.02%11,712
0.02%11,712

Institutional holders 288

View all →
HolderValue% of shares
BlackRock, Inc.$683.60M8.94%
Vanguard Group Inc$664.82M9.02%
RA Capital Management, L.P.$579.81M9.68%
Baker Bros. Advisors LP$487.42M8.14%
Primecap Management CO/CA$372.36M5.05%
NEA Management Company, LLC$311.48M4.23%
State Street Corporation$285.73M3.74%
Perceptive Advisors LLC$206.45M3.45%
The Goldman Sachs Group, Inc.$195.98M2.66%
Fmr LLC$182.64M2.48%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 1, 2026Meeker David P
CEO
OtherCommon Stock$3.44M-32K
-11.65%
239,016
0.35% of shares
low
Feb 1, 2026Smith Hunter C
Executive
OtherCommon Stock$1.17M-11K
-7.52%
132,165
0.19% of shares
low
Feb 1, 2026Lee Jennifer Kayden
Executive
OtherCommon Stock$1.01M-9K
-32.44%
19,233
0.03% of shares
low
Feb 1, 2026Shulman Joseph
Executive
OtherCommon Stock$709.2K-7K
-25.54%
18,970
0.03% of shares
low
Feb 1, 2026Cramer Pamela J.
Executive
OtherCommon Stock$515.6K-5K
-13.87%
29,376
0.04% of shares
low
Mar 4, 2026German Christopher Paul
Executive
SellCommon Stock$502.8K-6K
-97.23%
160
<0.01% of shares
medium
May 15, 2026German Christopher Paul
Executive
SellCommon Stock$428.1K-5K
-100.00%
0
0.00% of shares
medium
Feb 5, 2026Smith Hunter C
Executive
SellCommon Stock$358.6K-3K
-2.62%
125,537
0.18% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A6,210,916
Vanguard Group IncPassive13G/A0
RA Capital Management, L.P.Passive13G/A
Primecap Management CO/CAPassive13G/A3,478,669
Perceptive Advisors LLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RYTM76243J105